John Kernan, TD Cowen managing director and retail analyst, joins 'Money Movers' to discuss how important Chinese exposure is ...

TD Cowen analyst Joseph Thome maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report) today. The company’s shares closed last Friday at $13.97. Don't Miss our Black Friday Offers: ...

TD Cowen lowered the firm’s price target on TransMedics (TMDX) to $120 from $175 and keeps a Buy rating on the shares. The firm said ...

We recently compiled a list of the 13 AI News You Probably Missed. In this article, we are going to take a look at where ...

Uncertainty about how US President-elect Donald Trump will apply tariffs has prompted an analyst at Toronto-Dominion Bank to ...

Life Science Tools and Diagnostics stocks are viewed favorably at TD Cowen despite concerns over Trump's policies and his HHS ...

On Friday, Baker Hughes Co (BKR) stock saw a decline, ending the day at $42.94 which represents a decrease of $-0.24 or -0.56% from the prior close of $43.18. The stock opened at $43.2 and touched a ...

Onex Corp. shares are climbing after the Canadian investment firm shed its only neutral rating, with TD Cowen upgrading the ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.19% of ...

We recently compiled a list of the 10 AI News and Ratings Investors Should Not Miss. In this article, we are going to take a ...

James Baugh, managing director, head of European market structure, TD Cowen was voted industry person of the year at last ...

Shares of investment management firm Onex rose Monday after TD Cowen upgraded the company's outlook on the back of its strong portfolio performance and fundraising. Shares recently traded 6.1% higher ...